(Total Views: 1204)
Posted On: 05/25/2017 9:28:21 AM
Post# of 3
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
$AVGR Hold for VISION study for the Company’s Lumivascular technology, New Cardiovascular Horizons (NCVH) annual conference on May 31, 2017
http://investors.avinger.com/phoenix.zhtml?c=...ID=2276569
http://investors.avinger.com/phoenix.zhtml?c=...ID=2276569
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)